Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Serologic Tests × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Interventions

Blood Specimen Collection 118 Surveys and Questionnaires 112 Specimen Handling 52 Observation 41 Radiotherapy 36 Interviews as Topic 35 Drug Therapy 29 Biopsy 27 Magnetic Resonance Spectroscopy 27 Surgical Procedures, Operative 27 Immune Checkpoint Inhibitors 22 Data Collection 21 Nivolumab 19 Magnetic Resonance Imaging 18 Therapeutics 17 Watchful Waiting 17 Liquid Biopsy 16 Immunotherapy 14 Standard of Care 14 Focus Groups 12 Radiosurgery 12 enzalutamide 12 palbociclib 12 pembrolizumab 12 Bevacizumab 11 Hematologic Tests 11 Positron Emission Tomography Computed Tomography 11 Tomography, X-Ray Computed 11 apalutamide 11 trastuzumab deruxtecan 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06111963 2025-07-16

Role of Inflammatory Markers in Sepsis

National Cancer Institute, Egypt

Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡